WARREN, N.J., June 13, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) ("Bellerophon" or the "Company"), a clinical-stage biotherapeutics company, announced today that Fabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the JMP Securities Life Sciences Conference, being held June 19-20, 2019, at the St. Regis New York Hotel in New York City.
| Bellerophon Presentation Details | ||||
| Date: | Thursday, June 20 | |||
| Time: | 11:00 AM Eastern Time | |||
| Location: | St. Regis New York Hotel, New York, NY | |||
| Webcast: | http://wsw.com/webcast/jmp39/blph/ | |||
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Posted In:
